General Range
VONOFORT 20
Price on request/100 · MOQ 100 boxes
VONOFORT 20 Tablets by Fortune Labs contain Vonoprazan 20 mg, a potassium-competitive acid blocker (P-CAB) used to manage acid-related gastrointestinal disorders. Vonoprazan works by inhibiting gastric acid secretion, helping reduce stomach acidity and promote healing of acid-related esophageal damage. VONOFORT 20 may be prescribed for gastroesophageal reflux disease (GERD), erosive esophagitis, and as part of combination therapy for Helicobacter pylori infection when clinically appropriate. Available in convenient 10 × 10 tablet packaging, this product is part of Fortune Labs' gastrointestinal pharmaceutical portfolio. Fortune Labs offers Gastro PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. Use only as prescribed by a healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Vonoprazan 20 mg
- Packaging Type
- Box Packaging
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Gastroesophageal Reflux Disease (GERD), acid reflux, erosive esophagitis, and other acid-related gastrointestinal conditions. Also used as part of com
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
